- Conference date: 15-17 January 2007
- Location: Shiga (Japan)
We recently established a drug development value chain collaborated by The SOSHO project (http://www.sosho.jp) and The BioGrid Project (http://www.biogrid.jp/) to accelerate new drug development. The SOSHO project provides new crystal growth methods including handling of protein crystals, and The BioGrid Project their developing software necessary for the in silico screening of promising drugs and the simulation of biological responses to proteins. We selected the two target enzymes; human hematopoietic prostaglandin D synthase (H‐PGDS) and orotidine 5′‐monophosphate decarboxylase from human malaria parasite plasmodium falciparum (PfOMPDC). The optimizing of HQL‐79, the inhibitor for human H‐PGDS and the screening of a lead compound for PfOMPDC by using in silico method are in study.
MOST READ THIS MONTH
MOST CITED THIS MONTH
Article metrics loading...